Influence of Genetic Polymorphism of CYP2C19 on Rifampicin Individual Dosage Regimen in Pulmonary Tuberculosis Patients

HU Pin,ZHANG Xiao-qing,HAO Xiao-hui,ZHANG Li-bin,CUI Zhen-ling
DOI: https://doi.org/10.3969/j.issn.1674-070x.2013.06.001.003.03
2013-01-01
Abstract:Objective To investigate the genetic polymorphism of CYP2C19 on the interindividual variation of rifampicin concentration in pulmonary tuberculosis patients and provide reference for rational medication in clinic.Methods Rifampicin Concentration in blood plasma were determined by HPLC in 142 pulmonary tuberculosis patients,CYP2C19 variants were detected using PCR-RELP method and futher studied the relationship between CYP2C19 polyphism and plasma concentration of RFP.Results Rifampicin Conclusion had great interindividual variation in different genotypes.RFP plasma concentration after administration 2 h,4 h and 8 h were significantly higher in CYP2C19 *2 AA homozygote than in CYP2C19 *2 GG homozygote.RFP plasma concentration after administration 8h were significantly higher in CYP2C19 *3 AA homozygote than in CYP2C19 *3 GG homozygote.Among other genotypes were not found statistical significance.Conclusion The data suggest that CYP2C19 polymorphism signifiantly impacts the concentration of RFP,and the pharmacogenomics is important to rationalize the medication of RFP.
What problem does this paper attempt to address?